Written March 2021. Learn more about forecasting therapies in a Covid-19 world. Tip 1: Look at the market from a patient perspective...
1st June 2021Read More
23rd April 2021Read More
The background. In this case study, we showcase our latest work with one of Europe’s largest, leading biotechnology pioneers, helping to facilitate better, more collaborative forecasting for hundreds of colleagues across the continent. For the company’s most recent forecasting cycle, our experts have worked to…
16th March 2021Read More
Consistency remains a fundamental building block of good forecasting. As the drive towards total business digitalisation continues, your teams can’t afford to be working in disconnected silos. Instead, give your people the power to collaborate in one unified interface, sharing applications and data seamlessly –…
9th February 2021Watch Video
This is a video about EpiCube, where the CEO of J+D Forecasting, David James, discusses the challenges and importance of data in response to our latest launch – EpiCube. More about EpiCube: https://jdforecasting.com/software/epicube/ The current challenges relating to data There’s lots of data out there…
3rd December 2020Read More
Part one of a four-part series of bitesize videos featuring expert led discussions on some of the global challenges surrounding pharmaceutical forecasting.
22nd October 2020Read More
A solution driven discussion to some of the global challenges surrounding Pharmaceutical Forecasting.
14th September 2020Read More
The Covid-19 pandemic has brought fast moving, changing variables placing extraordinary strains and uncertainty on society as whole. The changes in primary and secondary care globally have and will continue to affect future pharmaceutical forecasts for in-market and new product launches. High levels of unpredictability…
J+D Forecasting strike the balance between simplicity and complexity when modelling for the liquid tumour market12th August 2020
The Challenge Identify a clear, transparent, and logical way to structure a forecast model to identify the potential for a new therapy in leukaemia. The model would be complex because patients go through different stages of treatment within a single line of treatment (for example,…
23rd July 2020Read More
One of the world’s first global biotechnology companies a leader, in innovative scientific research in neurological diseases approached J+D Forecasting with a set of forecasting challenges.
21st July 2020Read More
Here we offer insight into how you can improve efficiencies in your long range strategic planning by moving to cloud-based software solutions.
20th July 2020Read More
Here we offer insight into the best practises for visualising your forecast, from thinking about your audience to interacting with data.
15th June 2020Read More
An article written by David James, IPI - International Pharmaceutical Industry